A molecular signature of depression in the amygdala.

OBJECTIVE Major depressive disorder is a heterogeneous illness with a mostly uncharacterized pathology. Recent gene array attempts to identify the molecular underpinnings of the illness in human postmortem subjects have not yielded a consensus. The authors hypothesized that controlling several sources of clinical and technical variability and supporting their analysis with array results from a parallel study in the unpredictable chronic mild stress (UCMS) rodent model of depression would facilitate identification of the molecular pathology of major depression. METHOD Large-scale gene expression was monitored in postmortem tissue from the anterior cingulate cortex and amygdala in paired male subjects with familial major depression and matched control subjects without major depression (N=14-16 pairs). Area dissections and analytical approaches were optimized. Results from the major depression group were compared with those from the UCMS study and confirmed by quantitative polymerase chain reaction and Western blot. Gene coexpression network analysis was performed on transcripts with conserved major depression-UCMS effects. RESULTS Significant and bidirectional predictions of altered gene expression were identified in amygdala between major depression and the UCMS model of depression. These effects were detected at the group level and also identified a subgroup of depressed subjects with a more homogeneous molecular pathology. This phylogenetically conserved "molecular signature" of major depression was reversed by antidepressants in mice, identified two distinct oligodendrocyte and neuronal phenotypes, and participated in highly cohesive and interactive gene coexpression networks. CONCLUSIONS These studies demonstrate that the biological liability to major depression is reflected in a persistent molecular pathology that affects the amygdala, and support the hypothesis of maladaptive changes in this brain region as a putative primary pathology in major depression.

[1]  J. John Mann,et al.  Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction. , 2003, BMC Bioinformatics.

[2]  M. Meaney,et al.  The effects of chronic antidepressant treatment in an animal model of anxiety , 2004, Psychopharmacology.

[3]  T. Paus Primate anterior cingulate cortex: Where motor control, drive and cognition interface , 2001, Nature Reviews Neuroscience.

[4]  W. Drevets,et al.  Discovering Endophenotypes for Major Depression , 2004, Neuropsychopharmacology.

[5]  Fuad G. Gwadry,et al.  Implication of SSAT by gene expression and genetic variation in suicide and major depression. , 2006, Archives of general psychiatry.

[6]  L. Parsons,et al.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. , 1999, The American journal of psychiatry.

[7]  N C Andreasen,et al.  The family history method using diagnostic criteria. Reliability and validity. , 1977, Archives of general psychiatry.

[8]  Matej Oresic,et al.  Systematic construction of gene coexpression networks with applications to human T helper cell differentiation process , 2007, Bioinform..

[9]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[10]  Anthony R. McIntosh,et al.  Limbic–frontal circuitry in major depression: a path modeling metanalysis , 2004, NeuroImage.

[11]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[12]  N. Uranova,et al.  Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium , 2004, Schizophrenia Research.

[13]  W. Drevets Prefrontal Cortical‐Amygdalar Metabolism in Major Depression , 1999, Annals of the New York Academy of Sciences.

[14]  David A Lewis,et al.  Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. , 2008, Archives of general psychiatry.

[15]  O. Sporns,et al.  Organization, development and function of complex brain networks , 2004, Trends in Cognitive Sciences.

[16]  J. Price,et al.  Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes , 2004, Biological Psychiatry.

[17]  R Hen,et al.  Lack of serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity , 2007, Molecular Psychiatry.

[18]  Homin K. Lee,et al.  Coexpression analysis of human genes across many microarray data sets. , 2004, Genome research.

[19]  J. Allman,et al.  The Anterior Cingulate Cortex , 2001, Annals of the New York Academy of Sciences.

[20]  R. Myers,et al.  Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[22]  M. Fava,et al.  Major Depressive Disorder , 2000, Neuron.

[23]  A. Meyer-Lindenberg,et al.  5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression , 2005, Nature Neuroscience.

[24]  James C. Overholser,et al.  Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder , 2007, The Journal of Neuroscience.

[25]  E. Sibille,et al.  Corticolimbic Transcriptome Changes are State-Dependent and Region-Specific in a Rodent Model of Depression and of Antidepressant Reversal , 2009, Neuropsychopharmacology.

[26]  R. Belmaker,et al.  Major depressive disorder. , 2008, The New England journal of medicine.

[27]  M E J Newman,et al.  Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Wim E Crusio,et al.  Agonistic Behavior and Unpredictable Chronic Mild Stress in Mice , 2003, Behavior genetics.

[29]  Huda Akil,et al.  Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain , 2004, Biological Psychiatry.

[30]  M. Raichle,et al.  Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism , 2002, European Neuropsychopharmacology.

[31]  D. Lewis,et al.  Large-scale estimates of cellular origins of mRNAs: Enhancing the yield of transcriptome analyses , 2008, Journal of Neuroscience Methods.

[32]  M. Thase,et al.  Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals , 2002, Biological Psychiatry.

[33]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[34]  R. Kerwin,et al.  Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. , 2001, Archives of general psychiatry.

[35]  JaneR . Taylor,et al.  Chronic Unpredictable Stress Decreases Cell Proliferation in the Cerebral Cortex of the Adult Rat , 2007, Biological Psychiatry.

[36]  H. Agrawal Extreme self-organization in networks constructed from gene expression data. , 2002, Physical review letters.

[37]  M. Cuesta,et al.  [Neurobiology of depression]. , 2002, Anales del sistema sanitario de Navarra.

[38]  J. Allman,et al.  Book Review: Two Phylogenetic Specializations in the Human Brain , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[39]  Paul Pavlidis,et al.  Gene Expression Profiling of Depression and Suicide in Human Prefrontal Cortex , 2004, Neuropsychopharmacology.

[40]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[41]  S. Chattarji,et al.  Chronic Stress Induces Contrasting Patterns of Dendritic Remodeling in Hippocampal and Amygdaloid Neurons , 2002, The Journal of Neuroscience.

[42]  H. Akaike A new look at the statistical model identification , 1974 .

[43]  Marcus E Raichle,et al.  Volumetric reduction in left subgenual prefrontal cortex in early onset depression , 2002, Biological Psychiatry.

[44]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Price,et al.  Low glial numbers in the amygdala in major depressive disorder , 2002, Biological Psychiatry.

[46]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  V. Arango,et al.  Molecular aging in human prefrontal cortex is selective and continuous throughout adult life , 2005, Biological Psychiatry.

[48]  Christopher S. Monk,et al.  Increased Amygdala Activity During Successful Memory Encoding in Adolescent Major Depressive Disorder: An fMRI Study , 2006, Biological Psychiatry.

[49]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[50]  S. Bergmann,et al.  Similarities and Differences in Genome-Wide Expression Data of Six Organisms , 2003, PLoS biology.

[51]  S. Horvath,et al.  Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks , 2006, BMC Genomics.

[52]  S. Skaper,et al.  Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor‐dependent and ‐independent mechanisms , 2004, Journal of neurochemistry.

[53]  S. Horvath,et al.  Functional organization of the transcriptome in human brain , 2008, Nature Neuroscience.

[54]  D. Paré,et al.  Glucocorticoids Enhance the Excitability of Principal Basolateral Amygdala Neurons , 2007, The Journal of Neuroscience.

[55]  C. Aston,et al.  Original Research Article , 2004 .

[56]  P. Willner Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS , 2005, Neuropsychobiology.

[57]  L. Glantz,et al.  Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. , 1997, Archives of general psychiatry.

[58]  Joakim Ekstrand,et al.  Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures , 2006 .